Home3378 โข HKG
add
Hanx Biopharmaceuticals (Wuhan) Co Ltd
Previous close
$17.51
Day range
$16.88 - $18.00
Year range
$13.48 - $29.48
Market cap
2.37B HKD
Avg Volume
1.12K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
MarketBeat
40 minutes ago
Sabre Corporation (NASDAQ:SABR) Given Average Rating of "Hold" by Brokerages
36.44%
Financials
Income Statement
Revenue
Net income
| (CNY) | 2024info | Y/Y change |
|---|---|---|
Revenue | 2.20M | -13.39% |
Operating expense | 120.91M | 89.27% |
Net income | -115.83M | -52.30% |
Net profit margin | -5.27K | -75.84% |
Earnings per share | โ | โ |
EBITDA | -116.70M | -91.85% |
Effective tax rate | 4.80% | โ |
Balance Sheet
Total assets
Total liabilities
| (CNY) | 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 173.88M | -14.92% |
Total assets | 501.47M | -14.46% |
Total liabilities | 284.87M | 6.83% |
Total equity | 216.60M | โ |
Shares outstanding | 11.79M | โ |
Price to book | 1.24 | โ |
Return on assets | -13.64% | โ |
Return on capital | -26.36% | โ |
Cash Flow
Net change in cash
| (CNY) | 2024info | Y/Y change |
|---|---|---|
Net income | -115.83M | -52.30% |
Cash from operations | -104.89M | -101.74% |
Cash from investing | 96.62M | 2.84% |
Cash from financing | 6.49M | -92.81% |
Net change in cash | -786.00K | -100.59% |
Free cash flow | 101.65M | โ |
About
Founded
2014
Website
Employees
55
